Cytochroma settles lawsuit with Genzyme
The lawsuit, in which Genzyme claimed that the former Bone Care employees had begu...Genzyme sues former Bone Care employees
. filed the suit in <a href="http://www.wiwd...Genzyme acquistion of Bone Care approved, significant impact forecast
...Genzyme Announces First Phase III Study of Tolevamer in Diarrhea Patients
Genzyme Corp. announced top-line data from the first of two Phase 3 clinical studies to assess the safety and efficacy of tolevamer liquid, an investigational, non-antibiotic , polymer therapy for patients with Clostridium difficile associated diarrhea (CDAD). The second Phase 3 study of tolevamer liquid is fully enrolled and results are expected later this year. In this first Phase...Genzyme Announces Results of Clinical Trial of Hylastan
CAMBRIDGE, Mass., July 05, 2007 /PRNewswire-FirstCall/ --Genzyme Corp. today announced top-line results from a pivotal studyinvestigating the safety and efficacy of hylastan in treating painin patients with osteoarthritis (OA) of the knee. Hylastan is beingdeveloped within Genzyme's program to introduce aviscosupplementation product that can be delivered through a singleknee injection. T...Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
CAMBRIDGE, Mass., June 18, 2007 - Genzyme Corp. (Nasdaq: GENZ)today announced the results of two new studies comparing a powderform of Renvela™ (sevelamer carbonate) to Renagel®tablets (sevelamer hydrochloride), including one trial in whichpatients received the powder form three times per day, and one inwhich it was administered once per day. Genzyme is developing Renvela...Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
CAMBRIDGE, Mass., June 18, 2007 /PRNewswire-FirstCall/ --Genzyme Corp. today announced the results of two new studiescomparing a powder form of Renvela (sevelamer carbonate) to Renageltablets (sevelamer hydrochloride), including one trial in whichpatients received the powder form three times per day, and one inwhich it was administered once per day. Genzyme is developing Renvela in...